ARENTFOX SCHIFF LLP

Lobbying for PHARVARIS, INC. · Late-stage biopharmaceutical company

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medicare/Medicaid

Advocacy of policies, legislation and coverage of new pharmaceuticals in the orphan drug space.

Pharmacy

Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.